ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,864 | 17,900 | 27,702 | 20,414 | 62,332 |
| Receivables | 95,793 | 83,745 | 73,162 | 82,379 | 72,129 |
| Inventories | 60,803 | 59,195 | 52,563 | 52,902 | 48,163 |
| TOTAL | $170,321 | $165,819 | $156,544 | $158,662 | $187,695 |
| Non-Current Assets | |||||
| PPE Net | 41,269 | 40,444 | 39,937 | 40,353 | 40,551 |
| Intangibles | 192,091 | 202,200 | 209,325 | 219,199 | 183,968 |
| Other Non-Current Assets | 57,509 | 54,118 | 59,585 | 64,018 | 44,575 |
| TOTAL | $290,869 | $296,762 | $308,847 | $323,570 | $269,094 |
| Total Assets | $461,190 | $462,581 | $465,391 | $482,232 | $456,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,243 | 12,785 | 12,329 | 11,872 | 9,941 |
| Accounts payable and accrued liabilities | 11,261 | 13,460 | 14,209 | 12,485 | 14,606 |
| Accrued Expenses | 50,075 | 49,543 | 44,139 | 39,458 | 36,678 |
| TOTAL | $78,565 | $75,900 | $79,088 | $79,356 | $61,676 |
| Non-Current Liabilities | |||||
| Long Term Debt | 172,443 | 175,161 | 177,879 | 188,094 | 175,808 |
| Deferred Revenues | 80 | 112 | 125 | 318 | 451 |
| Other Non-Current Liabilities | 14,482 | 16,420 | 17,080 | 13,611 | 6,514 |
| TOTAL | $186,925 | $191,581 | $194,959 | $201,705 | $182,322 |
| Total Liabilities | $265,490 | $267,481 | $274,047 | $281,061 | $243,998 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,365 | 12,358 | 12,315 | 12,341 | 12,107 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -4,972 | -1,337 | -1,771 | 10,565 | 17,584 |
| Other shareholders' equity | -11,683 | -13,356 | -14,295 | -11,900 | -4,594 |
| TOTAL | $195,700 | $195,100 | $191,344 | $201,171 | $212,791 |
| Total Liabilities And Equity | $461,190 | $462,581 | $465,391 | $482,232 | $456,789 |